Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Frontiers in Molecular Biosciences|March 20, 2023
A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic <i>Escherichia coli</i> infections in miceAsher J Williams, Katherine F Warfel, Primit Desai, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Bio-orthogonal Glycan Imaging of Culture Cells and Whole Animal <i>C. elegans</i> with Expansion MicroscopyJoe Chin-Hun Kuo, Marshall J Colville, Michelle R Sorkin, et al.
ACS Central Science|March 3, 2025
Bio-orthogonal Glycan Imaging of Cultured Cells and Whole Animal <i>C. elegans</i> with Expansion MicroscopyJoe Chin-Hun Kuo, Marshall J Colville, Michelle R Sorkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Shotgun scanning glycomutagenesis: A simple and efficient strategy for constructing and characterizing neoglycoproteinsMingji Li, Xiaolu Zheng, Sudhanshu Shanker, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Development of cell-free platforms for discovering, characterizing, and engineering post-translational modificationsDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2017
Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza ProtectionHannah C Watkins, C Garrett Rappazzo, Jaclyn S Higgins, et al.
Science Advances|February 4, 2021
On-demand biomanufacturing of protective conjugate vaccinesJessica C Stark, Thapakorn Jaroentomeechai, Tyler D Moeller, et al.
Biotechnology and Bioengineering|April 29, 2025
Scalable Cell-Free Production of Active T7 RNA PolymeraseRyan N Rezvani, Rochelle Aw, Wei Chan, et al.
Scientific Reports|November 23, 2017
A library of chemically defined human N-glycans synthesized from microbial oligosaccharide precursorsBrian S Hamilton, Joshua D Wilson, Marina A Shumakovich, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations <i>in vitro</i> and <i>in vivo</i>Tianzheng Ye, Azmain Alamgir, Cara M Robertus, et al.
Pageof 17